Neuland Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
17,198.00
225 (1.33%)
BSENSE

Jun 12, 03:55 PM

BSE+NSE Vol: 36.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "17,198.00",
    "chg": 225,
    "chgp": "1.33%",
    "dir": 1,
    "prev_price": "16,973.00",
    "mcapval": "21,994.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE794A01010",
    "curr_date": "Jun 12, 03:55 PM",
    "curr_time": "18:22 PM",
    "last_traded_at": "Jun 12, 03:55 PM IST",
    "bse_nse_vol": "36.18 k",
    "exc_status": "Active",
    "traded_date": "Jun 12, 2026",
    "traded_date_str": "2026 06 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4043167",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4043167.png",
        "date": "2026-06-10 08:00:56",
        "description": "Neuland Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, suggesting a strengthening price momentum amid a positive market backdrop for the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Neuland Laboratories Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4032704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4032704.png",
        "date": "2026-06-03 08:00:42",
        "description": "Neuland Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from bullish to mildly bullish trends. Despite a slight dip in the daily price, the stock’s medium- and long-term indicators reveal a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook."
      },
      {
        "title": "Neuland Laboratories Upgraded to Buy on Strong Financials and Bullish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-upgraded-to-buy-on-strong-financials-and-bullish-technicals-4030038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_mojoScore_4030038.png",
        "date": "2026-06-02 08:17:27",
        "description": "Neuland Laboratories Ltd has seen its investment rating upgraded from Hold to Buy, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. This upgrade, effective from 1 June 2026, comes amid robust quarterly results, sustained long-term growth, and a shift to bullish technical momentum, positioning the small-cap pharmaceutical firm favourably against market benchmarks."
      },
      {
        "title": "Neuland Laboratories Ltd Shows Strong Technical Momentum Amid Bullish Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-shows-strong-technical-momentum-amid-bullish-shift-4029159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_technicaldot_4029159.png",
        "date": "2026-06-02 08:01:32",
        "description": "Neuland Laboratories Ltd has exhibited a notable shift in technical momentum, transitioning from a sideways trend to a bullish stance. Supported by a strong MarketsMOJO Mojo Score upgrade to 77.0 and a Buy grade, the small-cap pharmaceutical player is demonstrating robust price action and technical signals that suggest sustained upward potential."
      },
      {
        "title": "Golden Cross Confirmed: Do Neuland Laboratories Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4027106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NeulandLaborato_goldencross_4027106.png",
        "date": "2026-06-01 18:00:19",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Neuland Laboratories Ltd, signalling a golden cross on 1 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination."
      },
      {
        "title": "Neuland Laboratories Gains 2.61%: Technical Shift and Valuation Concerns Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-gains-261-technical-shift-and-valuation-concerns-shape-the-week-4024561",
        "imagepath": "",
        "date": "2026-05-31 13:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 25:</strong> Stock opens at Rs.16,742.45, Sensex gains 1.23%</p>\n                    <p><strong>May 26:</strong> Stock surges 1.88% to Rs.17,056.90 despite Sensex decline</p>\n                    <p><strong>May 27:</strong> Downgrade to Hold announced amid mixed technical and valuation signals</p>\n                    <p><strong>May 29:</strong> Stock closes strong at Rs.17,067.90, up 1.84% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.16,634.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div>..."
      },
      {
        "title": "Neuland Laboratories Downgraded to Hold Amid Mixed Technical Signals and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-downgraded-to-hold-amid-mixed-technical-signals-and-valuation-concerns-4015839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_mojoScore_4015839.png",
        "date": "2026-05-27 08:05:16",
        "description": "Neuland Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 26 May 2026. This revision reflects a nuanced assessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite robust financial performance and strong returns, evolving technical indicators and valuation metrics have prompted a more cautious stance from analysts."
      },
      {
        "title": "Neuland Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4015570",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NeulandLaborato_technicaldot_4015570.png",
        "date": "2026-05-27 08:00:51",
        "description": "Neuland Laboratories Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a more sideways trend. Despite a 1.88% gain on 27 May 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a downgrade in its Mojo Grade from Buy to Hold."
      },
      {
        "title": "Neuland Laboratories Falls 6.35%: 4 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-falls-635-4-key-factors-driving-the-weekly-decline-3995541",
        "imagepath": "",
        "date": "2026-05-17 13:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens at Rs.17,548.30, declines 0.82%</p>\n                    <p><strong>12 May:</strong> Sharp drop of 3.12% amid low volume</p>\n                    <p><strong>13 May:</strong> Strong gap up and record quarterly results announced</p>\n                    <p><strong>14 May:</strong> Partial recovery with 1.51% gain</p>\n                    <p><strong>15 May:</strong> Week closes at Rs.16,570.70, down 0.79%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.17,548.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat..."
      }
    ],
    "total": 775,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "details": "Neuland Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update- Change in name of Registrar & Share Transfer Agent of the Company.",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Registrar & Share Transfer Agent Update",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Neuland Laboratories Limited has submitted to the Exchange a copy of half yearly disclosure on Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "Neuland Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled \"Press Release\".",
      "source": "NSE",
      "caption": "Neuland Laboratories Limited - Press Release",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>340%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Neuland Laboratories Gains 2.61%: Technical Shift and Valuation Concerns Shape the Week

2026-05-31 13:00:05

Key Events This Week

May 25: Stock opens at Rs.16,742.45, Sensex gains 1.23%

May 26: Stock surges 1.88% to Rs.17,056.90 despite Sensex decline

May 27: Downgrade to Hold announced amid mixed technical and valuation signals

May 29: Stock closes strong at Rs.17,067.90, up 1.84% on the day

stock-recommendationAnnouncement

Neuland Laboratories Limited - Registrar & Share Transfer Agent Update

09-Dec-2019 | Source : NSE

Neuland Laboratories Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update- Change in name of Registrar & Share Transfer Agent of the Company.

Neuland Laboratories Limited - Other General Purpose

27-Nov-2019 | Source : NSE

Neuland Laboratories Limited has submitted to the Exchange a copy of half yearly disclosure on Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Neuland Laboratories Limited - Press Release

15-Nov-2019 | Source : NSE

Neuland Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled "Press Release".

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Neuland Laboratories Ltd has declared 340% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Neuland Laboratories Ltd has announced 4:25 rights issue, ex-date: 13 Aug 14